Penthrox is approved in Canada
10 April 2018
ASX Announcement
Penthrox is approved in Canada
Medical Developments International Limited (ASX:MVP), announce today that PENTHROX®, has been granted Market Authorisation in Canada. The Marketing Authorisation issued by Health Canada allows PENTHROX® to be used for the short-term relief of moderate to severe acute pain, associated with trauma or interventional medical procedures, in conscious adult patients1.
For the full release, please refer to the following link: ASX Announcement – Penthrox is approved in Canada